Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-obesity Effects of Metabolaid® With AMPK-activating Capacity in Overweight Subjects: A Randomized Controlled Trial

NCT03568877 is registered in ClinicalTrials.gov with Universidad Miguel Hernandez de Elche as lead sponsor.

NCT NCT03568877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03568877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-obesity Effects of Metabolaid® With AMPK-activating Capacity in Overweight Subjects: A Randomized Controlled Trial
Lead sponsor
Universidad Miguel Hernandez de Elche
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2015
Completion date
July 31, 2015
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome